News

How Does Diabetes Harm the Heart?

Thursday, June 1, 2017
Diabetes is hard on the heart, increasing the risk for heart failure by two to three times in men and up to five times in women.
Borah-summit.jpg

Myers Defies the Odds to Help Rehabilitating Patients

Thursday, June 1, 2017
Dr. Myers, an alumni from the class of 2005, summits Mount Borah

Program Opens Doors for Underrepresented Groups

Thursday, June 1, 2017
The Summer Health Professions Education Program looks to assist students with building unique skills and career development

Study Questions Usefulness of ‘Rainbow Draw’

Thursday, June 1, 2017
Researchers hope their findings will reduce excess blood drawing

Can Fat “Feel” Fat?

Tuesday, May 30, 2017
Size-sensing protein controls glucose uptake and storage in fat cells.

Metabolic Enzyme Fuels Molecular Machinery of Memory

Tuesday, May 30, 2017
Iowa Neuroscience Institute Director Ted Abel co-authors study that finds epigenetics key to laying down spatial memories in mouse brain, providing possible new neurological medications.

Mgbechi Erondu: A writer entering residency

Tuesday, May 9, 2017
Mgbechi Erondu received a Master of Fine Arts from the Iowa Writers’ Workshop in 2016 and will graduate this month from the Carver College of Medicine.

UI to teach business and leadership skills to health care providers across Iowa

Monday, April 24, 2017
Medical school students learn a lot of about health care, but a professor in the University of Iowa’s Roy J. and Lucille A. Carver College of Medicine says learning about business would be helpful too.

Martinez and Lee honored with Diversity Catalyst Award

Monday, April 17, 2017
Experiences that Denise Martinez, MD, and Amy Lee, PhD, had growing up left lasting impressions and sparked strong personal commitments to improving diversity and inclusion in their workplaces and communities.

UI clinician spearheading promising melanoma immunotherapy treatment

Monday, April 17, 2017
Holden Comprehensive Cancer Center researcher Yousef Zakharia, MD, has presented promising data at a national meeting about combining a new investigational immunotherapy drug with an FDA-approved immunotherapy drug to treat patients with advanced melanoma.